These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 316435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H, Ohkubo T.
    Acta Haematol; 1987; 78(4):258-64. PubMed ID: 3122493
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 9. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR, Zimmerman TS.
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K, Saito H, Ratnoff OD.
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 14. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR, Sultan Y, Coller BS.
    N Engl J Med; 1977 May 05; 296(18):1024-30. PubMed ID: 300468
    [Abstract] [Full Text] [Related]

  • 17. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases.
    Sampson BM, Greaves M, Malia RG, Preston FE.
    Br J Haematol; 1983 Jun 05; 54(2):233-44. PubMed ID: 6405778
    [Abstract] [Full Text] [Related]

  • 18. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR, Hoyer LW, Rick ME, Ahr DJ.
    J Clin Invest; 1976 Jun 05; 57(6):1618-25. PubMed ID: 1084352
    [Abstract] [Full Text] [Related]

  • 19. Estrogens and surgery in women with von Willebrand's disease.
    Alperin JB.
    Am J Med; 1982 Sep 05; 73(3):367-71. PubMed ID: 6981997
    [Abstract] [Full Text] [Related]

  • 20. Acquired von Willebrand's syndrome during autoimmune disorder.
    Pizzuto J, Ambriz R, de la Paz Reyna M, Monrroy LM, Morales MR, Aviles A, Conte G, Enriquez R.
    Thromb Haemost; 1980 Feb 29; 42(5):1523-8. PubMed ID: 6966081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.